<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Docetaxel</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Docetaxel">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Docetaxel</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Docetaxel</b> (<b>DTX</b> or <b>DXL</b>), sold under the brand name <b>Taxotere</b> among others, is a chemotherapy medication used to treat a number of types of cancer.<span class="mw-ref" id="cite_ref-AHFS2016_1-0"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer.<span class="mw-ref" id="cite_ref-NCI2014_2-0"><a href="#cite_note-NCI2014-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It may be used by itself or along with other chemotherapy medication.<span class="mw-ref" id="cite_ref-AHFS2016_1-1"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It is given by slow injection into a vein.<span class="mw-ref" id="cite_ref-AHFS2016_1-2"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Docetaxel</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Docetaxel.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Docetaxel.svg.png" data-file-width="2102" data-file-height="1259" data-file-type="drawing" height="150" width="250"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Docetaxel3D.png" tppabs="https://ptable.com/wiki/compounds/I/m/Docetaxel3D.png" data-file-width="1000" data-file-height="726" data-file-type="bitmap" height="182" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Taxotere, Docecad, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/docetaxel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/docetaxel.html'" tppabs="https://www.drugs.com/monograph/docetaxel.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a696031.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a696031.html'" tppabs="https://medlineplus.gov/druginfo/meds/a696031.html" class="external text external">a696031</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Docetaxel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Docetaxel'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Docetaxel" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>IV</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L01CD02<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L01CD02  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L01CD02'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L01CD02" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>NA</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>&gt;98%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>11 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Biliary</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2<i>R</i>,3<i>S</i>)-3-[(<i>tert</i>-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=114977-28-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=114977-28-5'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=114977-28-5" class="external text external">114977-28-5</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/148124  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/148124'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/148124" class="external text external">148124</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6809  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6809'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6809" class="external text external">6809</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01248  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01248'" tppabs="https://www.drugbank.ca/drugs/DB01248" class="external text external">DB01248</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.130581.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.130581.html'" tppabs="http://www.chemspider.com/Chemical-Structure.130581.html" class="external text external">130581</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=699121PHCA  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=699121PHCA'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=699121PHCA" class="external text external">699121PHCA</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D07866  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D07866'" tppabs="https://www.kegg.jp/entry/D07866" class="external text external">D07866</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4672  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4672'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:4672" class="external text external">CHEBI:4672</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL92  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL92'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL92" class="external text external">ChEMBL92</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID0040464  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID0040464'" tppabs="https://comptox.epa.gov/dashboard/DTXSID0040464" class="external text external">DTXSID0040464</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.129.246  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.129.246'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.129.246" class="external text external">100.129.246</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>43</sub><span>H</span><sub>53</sub><span>N</span><span>O</span><sub>14</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">807.890</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%28C%29%28C%29C%29N%5BC%40%40H%5D%28c1ccccc1%29%5BC%40%40H%5D%28O%29C%28%3DO%29O%5BC%40%40H%5D4C%28%3DC3%2F%5BC%40%40H%5D%28O%29C%28%3DO%29%5BC%40%5D6%28%5BC%40H%5D%28%5BC%40H%5D%28OC%28%3DO%29c2ccccc2%29%5BC%40%40%5D%28O%29%28C3%28C%29C%29C4%29%5BC%40%40%5D5%28OC%28%3DO%29C%29%5BC%40H%5D%28OC5%29C%5BC%40%40H%5D6O%29C%29%2FC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%28C%29%28C%29C%29N%5BC%40%40H%5D%28c1ccccc1%29%5BC%40%40H%5D%28O%29C%28%3DO%29O%5BC%40%40H%5D4C%28%3DC3%2F%5BC%40%40H%5D%28O%29C%28%3DO%29%5BC%40%5D6%28%5BC%40H%5D%28%5BC%40H%5D%28OC%28%3DO%29c2ccccc2%29%5BC%40%40%5D%28O%29%28C3%28C%29C%29C4%29%5BC%40%40%5D5%28OC%28%3DO%29C%29%5BC%40H%5D%28OC5%29C%5BC%40%40H%5D6O%29C%29%2FC'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28OC%28C%29%28C%29C%29N%5BC%40%40H%5D%28c1ccccc1%29%5BC%40%40H%5D%28O%29C%28%3DO%29O%5BC%40%40H%5D4C%28%3DC3%2F%5BC%40%40H%5D%28O%29C%28%3DO%29%5BC%40%5D6%28%5BC%40H%5D%28%5BC%40H%5D%28OC%28%3DO%29c2ccccc2%29%5BC%40%40%5D%28O%29%28C3%28C%29C%29C4%29%5BC%40%40%5D5%28OC%28%3DO%29C%29%5BC%40H%5D%28OC5%29C%5BC%40%40H%5D6O%29C%29%2FC" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(OC(C)(C)C)N[C@@H](c1ccccc1)[C@@H](O)C(=O)O[C@@H]4C(=C3/[C@@H](O)C(=O)[C@]6([C@H]([C@H](OC(=O)c2ccccc2)[C@@](O)(C3(C)C)C4)[C@@]5(OC(=O)C)[C@H](OC5)C[C@@H]6O)C)/C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:ZDZOTLJHXYCWBA-VCVYQWHSSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461754129&page2=Docetaxel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461754129&page2=Docetaxel'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=461754129&page2=Docetaxel" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Common side effects include hair loss, low blood cell counts, numbness, shortness of breath, vomiting, and muscle pains.<span class="mw-ref" id="cite_ref-AHFS2016_1-3"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Other severe side effects include allergic reactions and future cancers.<span class="mw-ref" id="cite_ref-AHFS2016_1-4"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Side effects are more common in people with liver problems.<span class="mw-ref" id="cite_ref-AHFS2016_1-5"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Use during pregnancy may harm the baby.<span class="mw-ref" id="cite_ref-AHFS2016_1-6"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Docetaxel is in the taxane family of medications.<span class="mw-ref" id="cite_ref-BNF69_3-0"><a href="#cite_note-BNF69-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> It works by disrupting the normal function of microtubules and thereby stopping cell division.<span class="mw-ref" id="cite_ref-AHFS2016_1-7"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Docetaxel was patented in 1986 and approved for medical use in 1995.<span class="mw-ref" id="cite_ref-Fis2006_4-0"><a href="#cite_note-Fis2006-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is on the World Health Organization's List of Essential Medicines.<span class="mw-ref" id="cite_ref-WHO21st_5-0"><a href="#cite_note-WHO21st-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Docetaxel is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2016_1-8"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Chemotherapy_with_acral_cooling.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Chemotherapy_with_acral_cooling.jpg" data-file-width="1200" data-file-height="1600" data-file-type="bitmap" height="293" width="220"><div class="thumbcaption" style="text-align: left">A woman being treated with docetaxel chemotherapy for breast cancer. Cold mittens and wine coolers are placed on her hands and feet to prevent deleterious effects on the nails. Similar strategies can be used to prevent hair loss.</div></div></div>

<p>Docetaxel is used in the treatment of various cancers, including breast, lung, prostate, gastric, head and neck, and ovarian cancer.<span class="mw-ref" id="cite_ref-AHFS_6-0"><a href="#cite_note-AHFS-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Clinical data have shown docetaxel to have cytotoxic activity against breast, colorectal, lung, ovarian, prostate, liver, renal, gastric, and head and neck cancers and melanoma.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-0"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In hormone-refractory prostate cancer docetaxel improves life expectancy and overall life quality.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>The optimal dose scheduling of taxanes remains unconfirmed, but most studies find significant mortality benefit following either a three-week or a one-week administration schedule.  While a 2010 article in Current Clinical Pharmacology states, "weekly administration has emerged as the optimal schedule," the official docetaxel package insert recommends administration every three weeks.<span class="mw-ref" id="cite_ref-accessdata.fda.gov_9-0"><a href="#cite_note-accessdata.fda.gov-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Outcomes">Outcomes</h3></summary>
    
<p>Treatment with docetaxel increases survival time in people with certain types of cancer.<span class="mw-ref" id="cite_ref-Taxotere.comAbout_10-0"><a href="#cite_note-Taxotere.comAbout-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-1"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Clarke_11-0"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> While some clinical trials show median survival times to be increased by approximately only three months, the range of survival time is large.<span class="mw-ref" id="cite_ref-MedSafe_12-0"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Many people survive beyond five years with treatment from docetaxel, however it is difficult to attribute these findings directly to treatment with docetaxel.<span class="mw-ref" id="cite_ref-Tannock_13-0"><a href="#cite_note-Tannock-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Improved median survival time and response indicates that docetaxel slows metastatic cancer progression and can lead to disease-free survival.<span class="mw-ref" id="cite_ref-MedSafe_12-1"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Tannock_13-1"><a href="#cite_note-Tannock-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-0"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Conjunctive treatment of <a href="Prednisone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisone" title="Prednisone">prednisone</a> with docetaxel has been shown to lead to improved survival rate as well as improved quality of life and reduction of pain compared with treatments with <a href="Mitoxantrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitoxantrone" title="Mitoxantrone">mitoxantrone</a>.<span class="mw-ref" id="cite_ref-Tannock_13-2"><a href="#cite_note-Tannock-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>As well as inhibiting mitosis, the presence of docetaxel has been found to lead to the phosphorylation of the oncoprotein bcl-2, which leads to apoptosis of cancer cells that had previously blocked the apoptotic inducing mechanism, leading to tumour regression.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-2"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Enhanced effects of radiation therapy when combined with docetaxel has been observed in mice.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-3"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Docetaxel has also been found to have greater cellular uptake and is retained longer intracellularly than paclitaxel allowing docetaxel treatment to be effective with a smaller dose, leading to fewer and less severe adverse effects.<span class="mw-ref" id="cite_ref-Eisenhauer_15-0"><a href="#cite_note-Eisenhauer-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Breast_cancer">Breast cancer</h3></summary>
    

<p>Docetaxel and paclitaxel have comparable efficacy metastatic breast cancer but paclitaxel has less severe side effects.<span class="mw-ref" id="cite_ref-informahealthcare.com_16-0"><a href="#cite_note-informahealthcare.com-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Additionally, it has been noted that docetaxel is prone to cellular drug resistance via a variety of different mechanisms.<span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Monitoring_and_combination_use">Monitoring and combination use</h3></summary>
    
<p>Docetaxel is administered via a one-hour infusion every three weeks over ten or more cycles.<span class="mw-ref" id="cite_ref-MedSafe_12-2"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Treatment is given under the supervision of an oncologist. Strict monitoring of blood cell counts, liver function, serum electrolytes, serum creatinine, heart function and fluid retention is required to track the progression of tumour cells, response, adverse reactions and toxicity so that treatment can be modified or terminated if necessary.<span class="mw-ref" id="cite_ref-DrugDex_18-0"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Premedication with corticosteroids is recommended before each administration of docetaxel to reduce fluid retention and hypersensitive reactions.<span class="mw-ref" id="cite_ref-MedSafe_12-3"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Other medications will often be given to aid pain management and other symptoms. The treatment of breast cancer with doxorubicin and cyclophosphamide is enhanced by adjuvant treatment with docetaxel. Docetaxel is also used in combination with capecitabine, a DNA synthesis inhibitor.<span class="mw-ref" id="cite_ref-Goyle_19-0"><a href="#cite_note-Goyle-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:322px"><img src="../I/m/Docetaxel-Adverse-Effects-Graph.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Docetaxel-Adverse-Effects-Graph.jpg" data-file-width="570" data-file-height="522" data-file-type="bitmap" height="293" width="320"><div class="thumbcaption" style="text-align: left">Incidence of commonly experienced non-haematological adverse effects reported for treatment with docetaxel. Data from 40 phase II and phase III studies (n = 2045) with patients undergoing a one-hour infusion of 100 mg/m<sup>2</sup> docetaxel once every three weeks.</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:322px"><img src="../I/m/Docetaxel-Severe-Adverse-Effects-Graph.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Docetaxel-Severe-Adverse-Effects-Graph.jpg" data-file-width="517" data-file-height="343" data-file-type="bitmap" height="212" width="320"><div class="thumbcaption" style="text-align: left">Incidence of severe adverse effects reported in patients treated with docetaxel. Data from 40 phase II and phase III studies with patients undergoing a one-hour infusion of 100 mg/m<sup>2</sup> docetaxel once every three weeks.</div></div></div>
<p>Docetaxel is a cytotoxic chemotherapeutic agent.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-4"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comPharmacokinetics_20-0"><a href="#cite_note-Taxotere.comPharmacokinetics-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> As with all chemotherapy, adverse effects are common, and many side effects have been documented.<span class="mw-ref" id="cite_ref-MedSafe_12-4"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-1"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Because docetaxel is a cell-cycle-specific agent, it is cytotoxic to all dividing cells in the body.<span class="mw-ref" id="cite_ref-Rangp694_21-0"><a href="#cite_note-Rangp694-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> This includes tumour cells as well as hair follicles, bone marrow and other germ cells. For this reason, common chemotherapy side effects such as hair loss occur; sometimes this can be permanent. North west France are conducting a survey to establish exactly how many people are affected in this way. Independent studies show it could be as high as 6.3%, which puts it in the 'common and frequent' classification.<span class="mw-ref" id="cite_ref-Rangp694_21-1"><a href="#cite_note-Rangp694-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Haematological adverse effects include neutropenia (95.5%), anaemia (90.4%), febrile neutropenia (11.0%) and thrombocytopenia (8.0%).<span class="mw-ref" id="cite_ref-MedSafe_12-5"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-2"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Deaths due to toxicity accounted for 1.7% of the 2045 patients, and incidence was increased (9.8%) in patients with elevated baseline liver function tests (liver dysfunction).<span class="mw-ref" id="cite_ref-MedSafe_12-6"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-3"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Observations of severe side effects in the above 40 phase II and phase III studies were also recorded.</p>

<p>Many more side effects have been reported for conjunctive and adjuvant treatment with docetaxel as well as rare post-marketing events.<span class="mw-ref" id="cite_ref-MedSafe_12-7"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Contraindications_and_patient_factors">Contraindications and patient factors</h3></summary>
    
<p>Docetaxel is contraindicated for use with patients with a baseline neutrophil count less than 1500 cells/µL, a history of severe hypersensitivity reactions to docetaxel or polysorbate 80, severe liver impairment and pregnant or breast-feeding women.<span class="mw-ref" id="cite_ref-MedSafe_12-8"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-4"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>

<p>Side effects are experienced more frequently by patients of 65 years or older, but dosage is usually not decreased.<span class="mw-ref" id="cite_ref-MedSafe_12-9"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-DrugDex_18-1"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Kidney failure is thought not to be a significant factor for docetaxel dosage adjustment.<span class="mw-ref" id="cite_ref-DrugDex_18-2"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> Patients with hepatic insufficiency resulting in serum bilirubin greater than the upper limit of normal (ULN) should not be administered docetaxel, though this is not a stated contraindication. Dosage should be reduced by 20% in people who develop grade 3 or 4 diarrhea following exposure to docetaxel, hepatotoxicity defined by liver enzymes at levels greater than five times the ULN, and grade 2 palmer-planter toxicity.<span class="mw-ref" id="cite_ref-DrugDex_18-3"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Paediatric trials of docetaxel have been limited, and so safety of use in patients under 16 years has not been established.<span class="mw-ref" id="cite_ref-Clarke_11-1"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-DrugDex_18-4"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pregnancy">Pregnancy</h3></summary>
    
<p>Based on the limited data available, docetaxel appears to be safe in pregnancy if administered during the second and third trimesters; however, maternal and fetal risks should be weighed against benefits to determine the appropriate course of action.<span class="mw-ref" id="cite_ref-pmid23470115_22-0"><a href="#cite_note-pmid23470115-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-pmid22875836_23-0"><a href="#cite_note-pmid22875836-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span>
As with all chemotherapeutic agents, docetaxel administered to pregnant animals causes a variety of embryofetal toxicities, including death, when given during the period of organogenesis. Yet adequate studies investigating maternal and fetal effects in humans are lacking. One small systematic review that examined the use of taxanes to treat breast cancer in pregnancy showed that, out of 19 patients, only three congenital malformations occurred.<span class="mw-ref" id="cite_ref-ReferenceB_24-0"><a href="#cite_note-ReferenceB-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Two cases of cerebral ventriculomegaly observed in the study were documented prior to the administration of chemotherapy, suggesting an alternate cause of congenital malformation. The third case involved pyloric stenosis in an infant whose mother received a combination regimen of docetaxel, doxorubicin, cyclophosphamide and paclitaxel; because the fetus was exposed to multiple drugs in utero, it remains difficult to identify docetaxel as the causative teratogenic agent.<span class="mw-ref" id="cite_ref-ReferenceB_24-1"><a href="#cite_note-ReferenceB-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Further studies are needed to better assess the safety of docetaxel in pregnancy and determine appropriate dosing in pregnant women.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Drug_interactions">Drug interactions</h3></summary>
    
<p>Drug interactions may be the result of altered pharmacokinetics or pharmacodynamics due to one of the drugs involved.<span class="mw-ref" id="cite_ref-Clarke_11-2"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span>  <a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">Cisplatin</a>, <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="Doxorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxorubicin" title="Doxorubicin">doxorubicin</a>, <a href="Etoposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoposide" title="Etoposide">etoposide</a>, and <a href="Vinblastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinblastine" title="Vinblastine">vinblastine</a> are all potentially co-administered with docetaxel and did not modify docetaxel plasma binding in phase II studies.<span class="mw-ref" id="cite_ref-Urien_25-0"><a href="#cite_note-Urien-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Cisplatin is known to have a complex interaction with some CYPs and has in some events been shown to reduce docetaxel clearance by up to 25%.<span class="mw-ref" id="cite_ref-Clarke_11-3"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Anticonvulsants induce some metabolic pathways relevant to docetaxel. CYP450 and CYP3A show increased expression in response to the use of anticonvulsants and the metabolism of docetaxel metabolite M4 is processed by these CYPs. A corresponding increase in clearance of M4 by 25% is observed in patients taking phenytoin and phenobarbital, common anticonvulsants.<span class="mw-ref" id="cite_ref-Clarke_11-4"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<table class="wikitable">
<caption>Common and/or likely drug-drug combinations and known side effects from drug interactions</caption>
<tbody><tr><th>Drug interacting with docetaxel</th>
<th>Adverse effects from interaction</th></tr>
<tr>
<td>Cisplatin</td>
<td>Increased risk of delayed neuropathy</td></tr>
<tr>
<td>Cyclosporine, dalfopristin, erythromycin, itraconazole, ketoconazole, quinupristin, terfenadine, troleandomycin</td>
<td>Increased risk of docetaxel toxicity including some or all of the following: anaemia, leucopoenia, thrombocytopenia, fever, diarrhoea</td></tr>
<tr>
<td>Doxorubicin hydrochloride</td>
<td>Cholestatic jaundice and pseudomembranous colitis</td></tr>
<tr>
<td>Doxorubicin hydrochloride liposome</td>
<td>Increased doxorubicin exposure</td></tr>
<tr>
<td>Vaccinations for <i>Bacillus</i> of Calmette and Guerin, measles, mumps, poliovirus, rotavirus, rubella, smallpox, typhoid, varicella, yellow fever</td>
<td>Increased risk of infection by live vaccine</td></tr>
<tr>
<td>Thalidomide</td>
<td>Increased risk of venous thromboembolism</td></tr>
</tbody></table>

<p>Erythromycin, ketoconazole and cyclosporine are CYP3A4 inhibitors and therefore inhibit the metabolic pathway of docetaxel.<span class="mw-ref" id="cite_ref-Clarke_11-5"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> When used with anticonvulsants, which induce CYP3A4, an increased dose of docetaxel may be required.<span class="mw-ref" id="cite_ref-Clarke_11-6"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Pre-treatment with corticosteroids has been used to decrease hypersensitivity reactions and oedema in response to docetaxel and has shown no effect on the pharmacokinetics of docetaxel.<span class="mw-ref" id="cite_ref-Clarke_11-7"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The efficacy of docetaxel was improved by treatment with oral capecitabine, and after more than 27 months follow-up the survival benefit has been confirmed.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-5"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Doxorubicin was combined with docetaxel in one study of 24 patients and resulted in an increased AUC of docetaxel by 50 to 70%, indicating doxorubicin may affect the disposition of docetaxel.<span class="mw-ref" id="cite_ref-Clarke_11-8"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Etoposide has also been shown to decrease docetaxel clearance, though patient numbers for this observation have been low.<span class="mw-ref" id="cite_ref-Clarke_11-9"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Prednisone given with docetaxel led to improved survival, quality of life and pain management in patients with hormone-refractory prostate cancer.<span class="mw-ref" id="cite_ref-Tannock_13-3"><a href="#cite_note-Tannock-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<p>Docetaxel is of the chemotherapy drug class; taxane, and is a semi-synthetic analogue of <a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">paclitaxel</a> (Taxol), an extract from the bark of the rare Pacific yew tree, <i>Taxus brevifolia</i>.<span class="mw-ref" id="cite_ref-Clarke_11-10"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Due to scarcity of paclitaxel, extensive research was carried out leading to the formulation of docetaxel – an esterified product of 10-deacetyl baccatin III, which is extracted from the renewable and more readily available leaves of the European yew tree.</p>

<p>Docetaxel differs from paclitaxel at two positions in its chemical structure. It has a hydroxyl functional group on carbon 10, whereas paclitaxel has an acetate ester, and a tert-butyl carbamate ester exists on the phenylpropionate side chain instead of the benzamide in paclitaxel. The carbon 10 functional group change causes docetaxel to be more water-soluble than paclitaxel.<span class="mw-ref" id="cite_ref-Clarke_11-11"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Formulations_and_compositions">Formulations and compositions</h3></summary>
    
<p>Docetaxel is a white powder and is the active ingredient available in 20<span>&nbsp;</span>mg and 80<span>&nbsp;</span>mg Taxotere single-dose vials of concentrated anhydrous docetaxel in <a href="Polysorbate_80.htm" tppabs="https://ptable.com/wiki/compounds/A/Polysorbate_80" title="Polysorbate 80">polysorbate 80</a>.<span class="mw-ref" id="cite_ref-Clarke_11-12"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-10"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> The solution is a clear brown-yellow containing 40<span>&nbsp;</span>mg docetaxel and 1040<span>&nbsp;</span>mg polysorbate 80 per mL.<span class="mw-ref" id="cite_ref-MedSafe_12-11"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> 20<span>&nbsp;</span>mg Taxotere is distributed in a blister carton containing one single-dose vial of Taxotere (docetaxel) preparation in 0.5 mL sterile pyrogen-free anhydrous polysorbate 80, and a single dose Taxotere solvent vial containing 1.5 mL 13% ethanol in saline to be combined and diluted in a 250 mL infusion bag containing 0.9% sodium chloride or 5% glucose for administration.<span class="mw-ref" id="cite_ref-MedSafe_12-12"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> 80<span>&nbsp;</span>mg Taxotere is supplied identically but with 2.0 mL polysorbate 80 and 6.0 mL 13% ethanol in saline. The docetaxel and solvent vials are combined to give a solution of 10<span>&nbsp;</span>mg/mL and the required dose is drawn from this solution. Vials have an overfill to compensate for liquid loss during preparation, foaming, adhesion to vial walls and the dead volume. 20<span>&nbsp;</span>mg vials may be stored for 24 months below 25<span>&nbsp;</span>°C away from light and 80<span>&nbsp;</span>mg vials for 26 months in the same conditions.<span class="mw-ref" id="cite_ref-MedSafe_12-13"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Recently Sanofi has got approval for one-vial formulation. With this one-vial formulation, the preparation of the infusion solution is simplified by eliminating the first dilution step.
The two-vial and one-vial formulations contain the same drug substance, docetaxel trihydrate, and the same excipients (ethanol, polysorbate 80 and citric acid).
The one-vial formulation is administered as an aqueous intravenous solution that contains the same drug substance in the same concentration as the already approved two-vial formulation. The same grade, quality, and quantity of polysorbate 80 are present in the infusion solution of both formulations. The only difference between these two formulations is the quantity of ethanol.</p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Active_regions">Active regions</h3></summary>
    
<p>A model based on electron crystallographic density and nuclear magnetic resonance deconvolution has been proposed to explain the binding of docetaxel to β-tubulin.<span class="mw-ref" id="cite_ref-Snyder_26-0"><a href="#cite_note-Snyder-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> In this T-shaped/butterfly model, a deep hydrophobic cleft exists near the surface of the β-tubulin where three potential hydrogen bonds and multiple hydrophobic contacts bind to docetaxel. The hydrophobic pocket walls contain helices H1, H6, H7 and a loop between H6 and H7 that form hydrophobic interactions with the 3’-benzamido phenyl, 3’-phenyl, and the 2-benzoyl phenyl of docetaxel. 3’-phenyl also has contact with β-sheets B8 and B10. The C-8 methyl of docetaxel has Van der Waals interactions with two residues, Thr-276 and Gln-281 near the C-terminal end of β-tubulin. Docetaxel's O-21 experiences electrostatic attraction to Thr-276 and the C-12 methyl has proximity with Leu-371 on the loop between B9 and B10.<span class="mw-ref" id="cite_ref-Snyder_26-1"><a href="#cite_note-Snyder-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Absorption_and_distribution">Absorption and distribution</h3></summary>
    
<p>Oral bioavailability has been found to be 8% ±6% on its own and, when co-administered with <a href="Ciclosporin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a>, bioavailability increased to 90% ± 44%.<span class="mw-ref" id="cite_ref-DrugDex_18-5"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In practice, docetaxel is administered intravenously only to increase dose precision.<span class="mw-ref" id="cite_ref-Clarke_11-13"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-14"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comSafety_14-5"><a href="#cite_note-Taxotere.comSafety-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-Pharmac_27-0"><a href="#cite_note-Pharmac-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span> Evaluation of docetaxel pharmacokinetics in phase II and III clinical studies were with 100<span>&nbsp;</span>mg/m<sup>2</sup> dosages given over one-hour infusions every three weeks.<span class="mw-ref" id="cite_ref-Clarke_11-14"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Docetaxel was shown to be greater than 98% plasma protein bound independent of concentration at 37<span>&nbsp;</span>°C and pH 7.4<span class="mw-ref" id="cite_ref-Urien_25-1"><a href="#cite_note-Urien-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Docetaxel's plasma protein binding includes lipoproteins, alpha1 acid glycoprotein and albumin. Alpha1 acid glycoprotein is the most variable of these proteins inter-individually, especially in cancer patients and is therefore the main determinant of docetaxel's plasma binding variability.<span class="mw-ref" id="cite_ref-Urien_25-2"><a href="#cite_note-Urien-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Docetaxel interacted little with erythrocytes and was unaffected by the polysorbate 80 in its storage medium.<span class="mw-ref" id="cite_ref-Clarke_11-15"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Urien_25-3"><a href="#cite_note-Urien-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Polysorbate 80 may be the cause of hypersensitivity reasons in taxanes as recent studies indicated.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>The concentration-time profile of docetaxel was consistent with a three-compartment pharmacokinetic model.<span class="mw-ref" id="cite_ref-Clarke_11-16"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-15"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> An initial, relatively rapid decline, with an α half-life of mean 4.5 minutes is representative of distribution to peripheral compartments from the systemic circulation. A β half-life of mean 38.3 minutes and a relatively slow γ half-life of mean 12.2 hours represent the slow efflux of docetaxel from the peripheral compartment.<span class="mw-ref" id="cite_ref-Clarke_11-17"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-16"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>Administration a 100<span>&nbsp;</span>mg/m<sup>2</sup> dose over a one-hour infusion gave a mean total body clearance of 21 L/h/m<sup>2</sup> and a mean steady state volume of distribution of 73.8 L/m<sup>2</sup> or 123 L based on the mean BSA (body surface area) of 1.68 m<sup>2</sup>.<span class="mw-ref" id="cite_ref-Clarke_11-18"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-17"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Area under the plasma concentration-time curve had a mean value of 2.8<span>&nbsp;</span>mg.h/L.<span class="mw-ref" id="cite_ref-Clarke_11-19"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The Cmax of docetaxel was found to be 4.15 ± 1.35<span>&nbsp;</span>mg/L.<span class="mw-ref" id="cite_ref-Baker_30-0"><a href="#cite_note-Baker-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> Increased dose resulted in a linear increase of the area under the concentration-time curve and so it is concluded that dose is directly proportional to plasma concentration.<span class="mw-ref" id="cite_ref-Clarke_11-20"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Metabolism_and_excretion">Metabolism and excretion</h3></summary>
    
<p>Docetaxel is mainly metabolised in the liver by the cytochrome P450 CYP3A4 and CYP3A5 subfamilies of isoenzymes.<span class="mw-ref" id="cite_ref-Clarke_11-21"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-Taxotere.comPharmacokinetics_20-1"><a href="#cite_note-Taxotere.comPharmacokinetics-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-Guitton_31-0"><a href="#cite_note-Guitton-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> Metabolism is principally oxidative and at the tert-butylpropionate side chain, resulting first in an alcohol docetaxel (M2), which is then cyclised to three further metabolites (M1, M3 and M4).<span class="mw-ref" id="cite_ref-Guitton_31-1"><a href="#cite_note-Guitton-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span> M1 and M3 are two diastereomeric hydroxyoxazolidinones and M4 is an oxazolidinedione. Phase II trials of 577 patients showed docetaxel clearance is related to body surface area and to hepatic enzyme and alpha1 acid glycoprotein plasma levels.<span class="mw-ref" id="cite_ref-Urien_25-4"><a href="#cite_note-Urien-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> The following model represents docetaxel clearance in humans:</p>

<div style="text-align: center;"><b>CL = BSA · (22.1 − 3.55·AAG − 0.095·AGE + 0.2245·ALB) · (1 − 0.334·HEP12)</b></div>

<p>where CL is total body clearance (L/h), BSA is total body surface area (m<sup>2</sup>), AAG and ALB represent alpha1 acid glycoprotein and albumin plasma concentrations (g/L) respectively, and AGE is the patients age (years).<span class="mw-ref" id="cite_ref-Clarke_11-22"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> HEP12 represents a measure of hepatic dysfunction, affecting clearance of docetaxel. This final model accounted for a modest proportion of patients and identified most of the patients varying from the model (population median of CL = 35.6 L/h) as having hepatic dysfunction, indicating hepatic function as the most unpredictable factor with regards to clearance variability.<span class="mw-ref" id="cite_ref-Clarke_11-23"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Patients with significant hepatic dysfunction had an approximately 30% decrease in clearance of docetaxel and were also at a higher risk of toxicity poisoning from docetaxel treatment.<span class="mw-ref" id="cite_ref-Clarke_11-24"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Clearance has been shown from population pharmacokinetic studies to decrease significantly with age, increased alpha1 acid glycoprotein and albumin concentrations and decreased body surface area.<span class="mw-ref" id="cite_ref-Clarke_11-25"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Renal impairment is unlikely to affect metabolism or excretion of docetaxel as renal excretion contributes less than 5% of elimination.<span class="mw-ref" id="cite_ref-Clarke_11-26"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Limited data is available for docetaxel use in children with dosage between 55 and 75<span>&nbsp;</span>mg/m<sup>2</sup>. Two paediatric studies have taken place that show a mean clearance of 33 L/h/m<sup>2</sup> and concentration-time profiles best fitted by a two-compartmental model of distribution and elimination. Mean distribution half-life was 0.09 hours and mean elimination half-life was 1.4 hours in paediatric studies.<span class="mw-ref" id="cite_ref-Clarke_11-27"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>

<p>Biodistribution of 14C-labelled docetaxel in three patients showed the bulk of the drug to be metabolised and excreted in bile to the faeces.<span class="mw-ref" id="cite_ref-Clarke_11-28"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Of the radioactively labelled docetaxel administered, 80% was eliminated to the faeces with 5% in the urine over seven days, an indication that urinary excretion of docetaxel is minimal. Saliva contributed minimal excretion and no excretion was detected through pulmonary means.<span class="mw-ref" id="cite_ref-Clarke_11-29"><a href="#cite_note-Clarke-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The terminal half-life of docetaxel was determined as approximately 86 hours, through prolonged plasma sampling, contrary to the clinically stated terminal half-life of 10–18 hours.<span class="mw-ref" id="cite_ref-DrugDex_18-6"><a href="#cite_note-DrugDex-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-Baker_30-1"><a href="#cite_note-Baker-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism_of_action">Mechanism of action</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Molecular_target">Molecular target</h3></summary>
    
<p>Docetaxel binds to microtubules reversibly with high affinity and has a maximum stoichiometry of 1 mole docetaxel per mole tubulin in microtubules.<span class="mw-ref" id="cite_ref-Yvon_32-0"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> This binding stabilizes microtubules and prevents depolymerisation from calcium ions, decreased temperature and dilution, preferentially at the plus end of the microtubule.<span class="mw-ref" id="cite_ref-Yvon_32-1"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Docetaxel has been found to accumulate to higher concentration in ovarian adenocarcinoma cells than kidney carcinoma cells, which may contribute to the more effective treatment of ovarian cancer by docetaxel.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-6"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Yvon_32-2"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> It has also been found to lead to the phosphorylation of oncoprotein bcl-2, which is apoptosis-blocking in its oncoprotein form.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-7"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Modes_of_action">Modes of action</h3></summary>
    
<p>The cytotoxic activity of docetaxel is exerted by promoting and stabilising microtubule assembly, while preventing physiological microtubule depolymerisation/disassembly in the absence of <a href="Guanosine_triphosphate.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanosine_triphosphate" title="Guanosine triphosphate">GTP</a>.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-8"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Eisenhauer_15-1"><a href="#cite_note-Eisenhauer-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-RxListCP_33-0"><a href="#cite_note-RxListCP-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> This leads to a significant decrease in free tubulin, needed for microtubule formation and results in inhibition of mitotic cell division between metaphase and anaphase, preventing further cancer cell progeny.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-9"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-MedSafe_12-18"><a href="#cite_note-MedSafe-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Yvon_32-3"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<p>Because microtubules do not disassemble in the presence of docetaxel, they accumulate inside the cell and cause initiation of apoptosis.<span class="mw-ref" id="cite_ref-Yvon_32-4"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Apoptosis is also encouraged by the blocking of apoptosis-blocking bcl-2 oncoprotein.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-10"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Both <i>in vitro</i> and <i>in vivo</i> analysis show the anti-neoplastic activity of docetaxel to be effective against a wide range of known cancer cells, cooperate with other anti-neoplastic agents activity, and have greater cytotoxicity than paclitaxel, possibly due to its more rapid intracellular uptake.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-11"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>

<p>The main mode of therapeutic action of docetaxel is the suppression of microtubule dynamic assembly and disassembly, rather than microtubule bundling leading to apoptosis, or the blocking of bcl-2.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-12"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-Yvon_32-5"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cellular_responses">Cellular responses</h3></summary>
    
<p>Docetaxel exhibits cytotoxic activity on breast, colorectal, lung, ovarian, gastric, renal and prostate cancer cells.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-13"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Docetaxel does not block disassembly of interphase microtubules and so does not prevent entry into the mitotic cycle, but does block mitosis by inhibiting mitotic spindle assembly.<span class="mw-ref" id="cite_ref-Yvon_32-6"><a href="#cite_note-Yvon-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span> Resistance to paclitaxel or anthracycline doxorubicin does not necessarily indicate resistance to docetaxel.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-14"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Microtubules formed in the presence of docetaxel are of a larger size than those formed in the presence of paclitaxel, which may result in improved cytotoxic efficacy.<span class="mw-ref" id="cite_ref-Eisenhauer_15-2"><a href="#cite_note-Eisenhauer-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Abundant formation of microtubules and the prevention of replication caused by docetaxel leads to apoptosis of tumour cells and is the basis of docetaxel use as a cancer treatment.<span class="mw-ref" id="cite_ref-Eisenhauer_15-3"><a href="#cite_note-Eisenhauer-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> Docetaxel activity is significantly greater in ovarian and breast tumours than for lung tumours.<span class="mw-ref" id="cite_ref-Lyseng-Williamson_7-15"><a href="#cite_note-Lyseng-Williamson-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Discovery,_regulation_and_marketing">Discovery, regulation and marketing</h3></summary>
    
<p>Docetaxel is marketed worldwide under the name Taxotere by Sanofi-Aventis <span class="mw-ref" id="cite_ref-Taxotere.comAbout_10-1"><a href="#cite_note-Taxotere.comAbout-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> as well as Docefrez by Sun Pharma Global and Zytax by Zydus.<span class="mw-ref" id="cite_ref-34"><a href="#cite_note-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Annual sales of Taxotere in 2010 were €2.122 billion (<span style="white-space: nowrap">US$</span>3.1 billion). The patent expired in 2010.</p>

<p>Taxotere was developed  by Rhône-Poulenc Rorer (now Sanofi-Aventis) following from the discoveries of Pierre Potier at CNRS at Gif-sur-Yvette during his work on improvements to the production of <a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Taxol" title="Taxol" class="mw-redirect">Taxol</a>.<span class="mw-ref" id="cite_ref-35"><a href="#cite_note-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Costs">Costs</h3></summary>
    
<p>In the UK (in 2009) The cost of six cycles (18 weeks) of docetaxel at a dose of 75<span>&nbsp;</span>mg/m2 IV every 21 days is £5,262 (based on an average body surface area 1.75 m<sup>2</sup>).<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Exudative hyponychial dermatitis</li>
<li>Scleroderma-like reaction to taxanes</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2016-1"> <span id="mw-reference-text-cite_note-AHFS2016-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/docetaxel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/docetaxel.html'" tppabs="https://www.drugs.com/monograph/docetaxel.html" class="external text external">"Docetaxel"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161221162404/https://www.drugs.com/monograph/docetaxel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161221162404/https://www.drugs.com/monograph/docetaxel.html'" tppabs="https://web.archive.org/web/20161221162404/https://www.drugs.com/monograph/docetaxel.html" class="external text external">Archived</a> from the original on 21 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite></span></li><li id="cite_note-NCI2014-2"> <span id="mw-reference-text-cite_note-NCI2014-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel'" tppabs="https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel" class="external text external">"FDA Approval for Docetaxel"</a>. <i>National Cancer Institute</i>. 2006-10-05. <a href="javascript:if(confirm('https://web.archive.org/web/20161221163849/https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161221163849/https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel'" tppabs="https://web.archive.org/web/20161221163849/https://www.cancer.gov/about-cancer/treatment/drugs/fda-docetaxel" class="external text external">Archived</a> from the original on 21 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">21 December</span> 2016</span>.</cite></span></li><li id="cite_note-BNF69-3"> <span id="mw-reference-text-cite_note-BNF69-3" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 69</i> (69 ed.). British Medical Association. 2015. p.<span>&nbsp;</span>622. ISBN<span>&nbsp;</span><bdi>9780857111562</bdi>.</cite></span></li><li id="cite_note-Fis2006-4"> <span id="mw-reference-text-cite_note-Fis2006-4" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Janos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>512. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20161221092059/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161221092059/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512'" tppabs="https://web.archive.org/web/20161221092059/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA512" class="external text external">Archived</a> from the original on 2016-12-21.</cite></span></li><li id="cite_note-WHO21st-5"> <span id="mw-reference-text-cite_note-WHO21st-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-AHFS-6"> <span id="mw-reference-text-cite_note-AHFS-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/docetaxel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/docetaxel.html'" tppabs="https://www.drugs.com/monograph/docetaxel.html" class="external text external">"Docetaxel"</a>. <i>The American Society of Health-System Pharmacists</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20140423044720/http://www.drugs.com/monograph/docetaxel.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140423044720/http://www.drugs.com/monograph/docetaxel.html'" tppabs="https://web.archive.org/web/20140423044720/http://www.drugs.com/monograph/docetaxel.html" class="external text external">Archived</a> from the original on 23 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">20 April</span> 2014</span>.</cite></span></li><li id="cite_note-Lyseng-Williamson-7"> <span id="mw-reference-text-cite_note-Lyseng-Williamson-7" class="mw-reference-text"><cite id="CITEREFLyseng-WilliamsonFenton2005" class="citation journal cs1">Lyseng-Williamson KA, Fenton C (2005). "Docetaxel: a review of its use in metastatic breast cancer". <i>Drugs</i>. <b>65</b> (17): 2513–31. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200565170-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200565170-00007'" tppabs="https://doi.org/10.2165%2F00003495-200565170-00007" class="external text external">10.2165/00003495-200565170-00007</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16296875  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16296875'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16296875" class="external text external">16296875</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFShelleyHarrison,_CColes,_BStaffurth,_J2006" class="citation journal cs1">Shelley, M; Harrison, C; Coles, B; Staffurth, J; Wilt, TJ; Mason, MD (Oct 18, 2006). "Chemotherapy for hormone-refractory prostate cancer". <i>The Cochrane Database of Systematic Reviews</i> (4): CD005247. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD005247.pub2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD005247.pub2'" tppabs="https://doi.org/10.1002%2F14651858.CD005247.pub2" class="external text external">10.1002/14651858.CD005247.pub2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17054249  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17054249'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17054249" class="external text external">17054249</a>.</cite></span></li><li id="cite_note-accessdata.fda.gov-9"> <span id="mw-reference-text-cite_note-accessdata.fda.gov-9" class="mw-reference-text"><a href="javascript:if(confirm('http://accessdata.fda.gov/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://accessdata.fda.gov/'" tppabs="http://accessdata.fda.gov/" class="external free external">http://accessdata.fda.gov</a> <a href="javascript:if(confirm('https://web.archive.org/web/20140428162939/http://www.accessdata.fda.gov/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140428162939/http://www.accessdata.fda.gov/'" tppabs="https://web.archive.org/web/20140428162939/http://www.accessdata.fda.gov/" class="external text external">Archived</a><span> 2014-04-28 at the </span>Wayback Machine, Docetaxel Package Insert, Last updated 2/2011</span></li><li id="cite_note-Taxotere.comAbout-10"> <span id="mw-reference-text-cite_note-Taxotere.comAbout-10" class="mw-reference-text">Anonymous. Taxotere.com for Healthcare Professionals: About. Sanofi-aventis U.S. LLC. <cite class="citation web cs1"><a href="javascript:if(confirm('http://www.taxotere.com/professional/about/index.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.taxotere.com/professional/about/index.do'" tppabs="http://www.taxotere.com/professional/about/index.do" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20061109200959/http://www.taxotere.com/professional/about/index.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061109200959/http://www.taxotere.com/professional/about/index.do'" tppabs="https://web.archive.org/web/20061109200959/http://www.taxotere.com/professional/about/index.do" class="external text external">Archived</a> from the original on 2006-11-09<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-10-02</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> (17 Sep 2006). Last modified Jul 2005.</span></li><li id="cite_note-Clarke-11"> <span id="mw-reference-text-cite_note-Clarke-11" class="mw-reference-text"><cite id="CITEREFClarkeRivory1999" class="citation journal cs1">Clarke SJ, Rivory LP (February 1999). <a href="javascript:if(confirm('http://content.wkhealth.com/linkback/openurl?issn=0312-5963&volume=36&issue=2&spage=99  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://content.wkhealth.com/linkback/openurl?issn=0312-5963&volume=36&issue=2&spage=99'" tppabs="http://content.wkhealth.com/linkback/openurl?issn=0312-5963&volume=36&issue=2&spage=99" class="external text external">"Clinical pharmacokinetics of docetaxel"</a>. <i>Clin Pharmacokinet</i>. <b>36</b> (2): 99–114. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003088-199936020-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003088-199936020-00002'" tppabs="https://doi.org/10.2165%2F00003088-199936020-00002" class="external text external">10.2165/00003088-199936020-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10092957  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10092957'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10092957" class="external text external">10092957</a>.</cite></span></li><li id="cite_note-MedSafe-12"> <span id="mw-reference-text-cite_note-MedSafe-12" class="mw-reference-text">Anonymous. Taxotere Docetaxel concentrate for infusion. Medsafe. <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20100603164834/http://www.medsafe.govt.nz/profs/Datasheet/d/DocetaxelEbeweinj.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20100603164834/http://www.medsafe.govt.nz/profs/Datasheet/d/DocetaxelEbeweinj.htm'" tppabs="https://web.archive.org/web/20100603164834/http://www.medsafe.govt.nz/profs/Datasheet/d/DocetaxelEbeweinj.htm" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www.medsafe.govt.nz/profs/datasheet/d/DocetaxelEbeweinj.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medsafe.govt.nz/profs/datasheet/d/DocetaxelEbeweinj.htm'" tppabs="http://www.medsafe.govt.nz/profs/datasheet/d/DocetaxelEbeweinj.htm" class="external text external">the original</a> on 2010-06-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-06-10</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> Likely replacement for dead link <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20051228000129/http://medsafe.govt.nz/Profs/datasheet/t/taxotereinf.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20051228000129/http://medsafe.govt.nz/Profs/datasheet/t/taxotereinf.htm'" tppabs="https://web.archive.org/web/20051228000129/http://medsafe.govt.nz/Profs/datasheet/t/taxotereinf.htm" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www.medsafe.govt.nz/profs/Datasheet/t/taxotereinf.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.medsafe.govt.nz/profs/Datasheet/t/taxotereinf.htm'" tppabs="http://www.medsafe.govt.nz/profs/Datasheet/t/taxotereinf.htm" class="external text external">the original</a> on 2005-12-28<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-09-17</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> (25 Sep 2006). Last modified 6 Feb 2006.</span></li><li id="cite_note-Tannock-13"> <span id="mw-reference-text-cite_note-Tannock-13" class="mw-reference-text"><cite id="CITEREFTannockde_WitBerry2004" class="citation journal cs1">Tannock IF, de Wit R, Berry WR,  et al. (October 2004). "Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer". <i>N. Engl. J. Med</i>. <b>351</b> (15): 1502–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa040720  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa040720'" tppabs="https://doi.org/10.1056%2FNEJMoa040720" class="external text external">10.1056/NEJMoa040720</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15470213  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15470213'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15470213" class="external text external">15470213</a>.</cite></span></li><li id="cite_note-Taxotere.comSafety-14"> <span id="mw-reference-text-cite_note-Taxotere.comSafety-14" class="mw-reference-text">Anonymous. Taxotere.com for Healthcare Professionals: Efficacy and Safety. Sanofi-aventis U.S. LLC. <cite class="citation web cs1"><a href="javascript:if(confirm('http://www.taxotere.com/professional/about/efficacy_safety.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.taxotere.com/professional/about/efficacy_safety.do'" tppabs="http://www.taxotere.com/professional/about/efficacy_safety.do" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20061111064251/http://www.taxotere.com/professional/about/efficacy_safety.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061111064251/http://www.taxotere.com/professional/about/efficacy_safety.do'" tppabs="https://web.archive.org/web/20061111064251/http://www.taxotere.com/professional/about/efficacy_safety.do" class="external text external">Archived</a> from the original on 2006-11-11<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-10-02</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> (24 Sep 2006). Last modified Jul 2005.</span></li><li id="cite_note-Eisenhauer-15"> <span id="mw-reference-text-cite_note-Eisenhauer-15" class="mw-reference-text"><cite id="CITEREFEisenhauerVermorken1998" class="citation journal cs1">Eisenhauer EA, Vermorken JB (January 1998). <a href="javascript:if(confirm('http://content.wkhealth.com/linkback/openurl?issn=0012-6667&volume=55&issue=1&spage=5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://content.wkhealth.com/linkback/openurl?issn=0012-6667&volume=55&issue=1&spage=5'" tppabs="http://content.wkhealth.com/linkback/openurl?issn=0012-6667&volume=55&issue=1&spage=5" class="external text external">"The taxoids. Comparative clinical pharmacology and therapeutic potential"</a>. <i>Drugs</i>. <b>55</b> (1): 5–30. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199855010-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199855010-00002'" tppabs="https://doi.org/10.2165%2F00003495-199855010-00002" class="external text external">10.2165/00003495-199855010-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9463787  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9463787'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9463787" class="external text external">9463787</a>.</cite></span></li><li id="cite_note-informahealthcare.com-16"> <span id="mw-reference-text-cite_note-informahealthcare.com-16" class="mw-reference-text"><cite id="CITEREFQiShenLinSun2012" class="citation journal cs1">Qi, Wei-Xiang; Shen, Zan; Lin, Feng; Sun, Yuan-jue; Min, Da-liu; Tang, Li-Na; He, Ai-Na; Yao, Yang (26 December 2012). "Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials". <i>Current Medical Research and Opinion</i>. <b>29</b> (2): 117–125. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F03007995.2012.756393  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F03007995.2012.756393'" tppabs="https://doi.org/10.1185%2F03007995.2012.756393" class="external text external">10.1185/03007995.2012.756393</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23216340  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23216340'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23216340" class="external text external">23216340</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFAlkenKelly2013" class="citation journal cs1">Alken, S; Kelly, CM (14 October 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099" class="external text external">"Benefit risk assessment and update on the use of docetaxel in the management of breast cancer"</a>. <i>Cancer Management and Research</i>. <b>5</b>: 357–65. doi:<a href="javascript:if(confirm('https://doi.org/10.2147%2FCMAR.S49321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2147%2FCMAR.S49321'" tppabs="https://doi.org/10.2147%2FCMAR.S49321" class="external text external">10.2147/CMAR.S49321</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798099" class="external text external">3798099</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24143122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24143122'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24143122" class="external text external">24143122</a>.</cite></span></li><li id="cite_note-DrugDex-18"> <span id="mw-reference-text-cite_note-DrugDex-18" class="mw-reference-text">Anonymous. Drugdex Evaluations: Docetaxel. Thomson MICROMEDEX. <a href="javascript:if(confirm('http://www.library.auckland.ac.nz/databases/learn_database/public.asp?record=micromedex  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.library.auckland.ac.nz/databases/learn_database/public.asp?record=micromedex#Drugdex'" tppabs="http://www.library.auckland.ac.nz/databases/learn_database/public.asp?record=micromedex#Drugdex" class="external free external">http://www.library.auckland.ac.nz/databases/learn_database/public.asp?record=micromedex#Drugdex</a> (26 Sep 2006). Last modified 2006.</span></li><li id="cite_note-Goyle-19"> <span id="mw-reference-text-cite_note-Goyle-19" class="mw-reference-text"><cite id="CITEREFGoyleMaraveyas2005" class="citation journal cs1">Goyle S, Maraveyas A (2005). <a href="javascript:if(confirm('http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf'" tppabs="http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf" class="external text external">"Chemotherapy for colorectal cancer"</a>. <i>Dig Surg</i>. <b>22</b> (6): 401–14. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000091441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000091441'" tppabs="https://doi.org/10.1159%2F000091441" class="external text external">10.1159/000091441</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16479107  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16479107'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16479107" class="external text external">16479107</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20121006101922/http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20121006101922/http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf'" tppabs="https://web.archive.org/web/20121006101922/http://content.karger.com/produktedb/produkte.asp?DOI=91441&typ=pdf" class="external text external">Archived</a> from the original on 2012-10-06.</cite></span></li><li id="cite_note-Taxotere.comPharmacokinetics-20"> <span id="mw-reference-text-cite_note-Taxotere.comPharmacokinetics-20" class="mw-reference-text">Anonymous. Taxotere.com for Healthcare Professionals: Pharmacokinetics. Sanofi-aventis U.S. LLC. <cite class="citation web cs1"><a href="javascript:if(confirm('http://www.taxotere.com/professional/about/pharmacokinetics.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.taxotere.com/professional/about/pharmacokinetics.do'" tppabs="http://www.taxotere.com/professional/about/pharmacokinetics.do" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20061111064303/http://www.taxotere.com/professional/about/pharmacokinetics.do  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061111064303/http://www.taxotere.com/professional/about/pharmacokinetics.do'" tppabs="https://web.archive.org/web/20061111064303/http://www.taxotere.com/professional/about/pharmacokinetics.do" class="external text external">Archived</a> from the original on 2006-11-11<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-10-02</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> (23 Sep 2006). Last modified Jul 2005.</span></li><li id="cite_note-Rangp694-21"> <span id="mw-reference-text-cite_note-Rangp694-21" class="mw-reference-text">Rang HP, Dale MM, Ritter JM, Moore PK. <i>Pharmacology</i>. 5th ed. London: Churchill Livingstone; 2003. p. 694-8.</span></li><li id="cite_note-pmid23470115-22"> <span id="mw-reference-text-cite_note-pmid23470115-22" class="mw-reference-text"><cite class="citation journal cs1">Koren G, Carey N, Gagnon R, Maxwell C, Nulman I, Senikas V (March 2013). "Cancer chemotherapy and pregnancy". <i>J Obstet Gynaecol Can</i>. <b>35</b> (3): 263–80. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs1701-2163%2815%2930999-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs1701-2163%2815%2930999-3'" tppabs="https://doi.org/10.1016%2Fs1701-2163%2815%2930999-3" class="external text external">10.1016/s1701-2163(15)30999-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23470115  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23470115'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23470115" class="external text external">23470115</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-pmid22875836-23"> <span id="mw-reference-text-cite_note-pmid22875836-23" class="mw-reference-text"><cite class="citation journal cs1">Cardonick E, Bhat A, Gilmandyar D, Somer R (2012). <a href="javascript:if(confirm('https://doi.org/10.1093/annonc/mds170  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/annonc/mds170'" tppabs="https://doi.org/10.1093/annonc/mds170" class="external text external">"Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature"</a>. <i>Ann. Oncol</i>. <b>23</b> (12): 3016–23. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fannonc%2Fmds170  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fannonc%2Fmds170'" tppabs="https://doi.org/10.1093%2Fannonc%2Fmds170" class="external text external">10.1093/annonc/mds170</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22875836  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22875836'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22875836" class="external text external">22875836</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-ReferenceB-24"> <span id="mw-reference-text-cite_note-ReferenceB-24" class="mw-reference-text">Gideon Koren, Nathalie Carey, Robert Gagnon, et al. Cancer Chemotherapy and Pregnancy, "Journal of Obstetrics and Gynecology Canada", March 2013</span></li><li id="cite_note-Urien-25"> <span id="mw-reference-text-cite_note-Urien-25" class="mw-reference-text"><cite id="CITEREFUrienBarréMorinPaccaly1996" class="citation journal cs1">Urien S, Barré J, Morin C, Paccaly A, Montay G, Tillement JP (1996). "Docetaxel serum protein binding with high affinity to alpha 1-acid glycoprotein". <i>Invest New Drugs</i>. <b>14</b> (2): 147–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2FBF00210785  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2FBF00210785'" tppabs="https://doi.org/10.1007%2FBF00210785" class="external text external">10.1007/BF00210785</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8913835  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8913835'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8913835" class="external text external">8913835</a>.</cite></span></li><li id="cite_note-Snyder-26"> <span id="mw-reference-text-cite_note-Snyder-26" class="mw-reference-text"><cite id="CITEREFSnyderNettlesCornettDowning2001" class="citation journal cs1">Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E (April 2001). <a href="javascript:if(confirm('http://www.pnas.org/cgi/pmidlookup?view=long&pmid=11309480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.pnas.org/cgi/pmidlookup?view=long&pmid=11309480'" tppabs="http://www.pnas.org/cgi/pmidlookup?view=long&pmid=11309480" class="external text external">"The binding conformation of Taxol in β-tubulin: A model based on electron crystallographic density"</a>. <i>Proc. Natl. Acad. Sci. U.S.A</i>. <b>98</b> (9): 5312–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1073%2Fpnas.051309398  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1073%2Fpnas.051309398'" tppabs="https://doi.org/10.1073%2Fpnas.051309398" class="external text external">10.1073/pnas.051309398</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33206  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33206'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC33206" class="external text external">33206</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11309480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11309480'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11309480" class="external text external">11309480</a>.</cite></span></li><li id="cite_note-Pharmac-27"> <span id="mw-reference-text-cite_note-Pharmac-27" class="mw-reference-text">Anonymous. New Zealand Pharmaceutical Schedule. Wellington: PHARMAC; 2006. p. 133.</span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><a href="javascript:if(confirm('http://www.communityoncology.net/co/journal/articles/0709425.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.communityoncology.net/co/journal/articles/0709425.pdf'" tppabs="http://www.communityoncology.net/co/journal/articles/0709425.pdf" class="external free external">http://www.communityoncology.net/co/journal/articles/0709425.pdf</a> </span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ehealthme.com/ds/taxotere/hypersensitivity  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ehealthme.com/ds/taxotere/hypersensitivity'" tppabs="http://www.ehealthme.com/ds/taxotere/hypersensitivity" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20150701165304/http://www.ehealthme.com/ds/taxotere/hypersensitivity  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150701165304/http://www.ehealthme.com/ds/taxotere/hypersensitivity'" tppabs="https://web.archive.org/web/20150701165304/http://www.ehealthme.com/ds/taxotere/hypersensitivity" class="external text external">Archived</a> from the original on 2015-07-01<span class="reference-accessdate">. Retrieved <span class="nowrap">2012-05-09</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-Baker-30"> <span id="mw-reference-text-cite_note-Baker-30" class="mw-reference-text"><cite id="CITEREFBakerZhaoLee2004" class="citation journal cs1">Baker SD, Zhao M, Lee CK,  et al. (March 2004). <a href="javascript:if(confirm('http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=15041715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=15041715'" tppabs="http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=15041715" class="external text external">"Comparative pharmacokinetics of weekly and every-three-weeks docetaxel"</a>. <i>Clin. Cancer Res</i>. <b>10</b> (6): 1976–83. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F1078-0432.CCR-0842-03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F1078-0432.CCR-0842-03'" tppabs="https://doi.org/10.1158%2F1078-0432.CCR-0842-03" class="external text external">10.1158/1078-0432.CCR-0842-03</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15041715  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15041715'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15041715" class="external text external">15041715</a>.</cite></span></li><li id="cite_note-Guitton-31"> <span id="mw-reference-text-cite_note-Guitton-31" class="mw-reference-text"><cite id="CITEREFGuittonCohenTranchand2005" class="citation journal cs1">Guitton J, Cohen S, Tranchand B,  et al. (2005). "Quantification of docetaxel and its main metabolites in human plasma by liquid chromatography/tandem mass spectrometry". <i>Rapid Commun. Mass Spectrom</i>. <b>19</b> (17): 2419–26. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2005RCMS...19.2419G  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2005RCMS...19.2419G'" tppabs="https://ui.adsabs.harvard.edu/abs/2005RCMS...19.2419G" class="external text external">2005RCMS...19.2419G</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Frcm.2072  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Frcm.2072'" tppabs="https://doi.org/10.1002%2Frcm.2072" class="external text external">10.1002/rcm.2072</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16059877  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16059877'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16059877" class="external text external">16059877</a>.</cite></span></li><li id="cite_note-Yvon-32"> <span id="mw-reference-text-cite_note-Yvon-32" class="mw-reference-text"><cite id="CITEREFYvonWadsworthJordan1999" class="citation journal cs1">Yvon AM, Wadsworth P, Jordan MA (April 1999). <a href="javascript:if(confirm('http://www.molbiolcell.org/cgi/pmidlookup?view=long&pmid=10198049  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.molbiolcell.org/cgi/pmidlookup?view=long&pmid=10198049'" tppabs="http://www.molbiolcell.org/cgi/pmidlookup?view=long&pmid=10198049" class="external text external">"Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells"</a>. <i>Mol. Biol. Cell</i>. <b>10</b> (4): 947–59. doi:<a href="javascript:if(confirm('https://doi.org/10.1091%2Fmbc.10.4.947  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1091%2Fmbc.10.4.947'" tppabs="https://doi.org/10.1091%2Fmbc.10.4.947" class="external text external">10.1091/mbc.10.4.947</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25218  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25218'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC25218" class="external text external">25218</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10198049  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10198049'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10198049" class="external text external">10198049</a>.</cite></span></li><li id="cite_note-RxListCP-33"> <span id="mw-reference-text-cite_note-RxListCP-33" class="mw-reference-text">Anonymous. Docetaxel: Clinical Pharmacology. RxList. <cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20061022202456/http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20061022202456/http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm'" tppabs="https://web.archive.org/web/20061022202456/http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm'" tppabs="http://www.rxlist.com/cgi/generic3/docetaxel_cp.htm" class="external text external">the original</a> on 2006-10-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-10-02</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> (24 Sep 2006). Last modified 29 Jun 2006.</span></li><li id="cite_note-34"> <span id="mw-reference-text-cite_note-34" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.rxlist.com/docefrez-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rxlist.com/docefrez-drug.htm'" tppabs="http://www.rxlist.com/docefrez-drug.htm" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20140512154932/http://www.rxlist.com/docefrez-drug.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140512154932/http://www.rxlist.com/docefrez-drug.htm'" tppabs="https://web.archive.org/web/20140512154932/http://www.rxlist.com/docefrez-drug.htm" class="external text external">Archived</a> from the original on 2014-05-12<span class="reference-accessdate">. Retrieved <span class="nowrap">2014-04-20</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li><li id="cite_note-35"> <span id="mw-reference-text-cite_note-35" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20070623011443/http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20070623011443/http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html'" tppabs="https://web.archive.org/web/20070623011443/http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html" class="external text external">"Archived copy"</a>. Archived from <a href="javascript:if(confirm('http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html'" tppabs="http://www.cnrs.fr/cw/en/pres/compress/mistpotier.html" class="external text external">the original</a> on 2007-06-23<span class="reference-accessdate">. Retrieved <span class="nowrap">2007-07-12</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span> Pierre Potier, chemist, 1998 CNRS Gold Medalist.</span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><a href="javascript:if(confirm('http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2009/jan-apr/Cabazitaxel.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2009/jan-apr/Cabazitaxel.pdf'" tppabs="http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2009/jan-apr/Cabazitaxel.pdf" class="external free external">http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2009/jan-apr/Cabazitaxel.pdf</a> ref<span>&nbsp;</span>: National Institute for Health and Clinical Excellence. Prostate cancer (hormone-refractory) — docetaxel: analysis of cost impact London: NICE; September 2006. <cite class="citation web cs1"><a href="javascript:if(confirm('http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354'" tppabs="http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354" class="external text external">"Archived copy"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20090321095030/http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20090321095030/http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354'" tppabs="https://web.archive.org/web/20090321095030/http://www.nice.org.uk/guidance/index.jsp?action=download&o=33354" class="external text external">Archived</a> from the original on 2009-03-21<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-06-10</span></span>.</cite><span class="cs1-maint citation-comment">CS1 maint: archived copy as title (link)</span></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('https://web.archive.org/web/20060428011003/http://products.sanofi-aventis.us/Taxotere/taxotere.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060428011003/http://products.sanofi-aventis.us/Taxotere/taxotere.html'" tppabs="https://web.archive.org/web/20060428011003/http://products.sanofi-aventis.us/Taxotere/taxotere.html" class="external text external">Taxotere</a> (manufacturer's prescribing information)</li>
<li><a href="javascript:if(confirm('http://www.taxotere.com/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.taxotere.com/'" tppabs="http://www.taxotere.com/" class="external text external">Taxotere</a> (manufacturer's website)</li>
<li><a href="javascript:if(confirm('https://web.archive.org/web/20141021191603/http://www.mosaiclife.co.uk/docetaxel-side-effects-on-nails/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141021191603/http://www.mosaiclife.co.uk/docetaxel-side-effects-on-nails/'" tppabs="https://web.archive.org/web/20141021191603/http://www.mosaiclife.co.uk/docetaxel-side-effects-on-nails/" class="external text external">Docetaxel and your nails</a> (infographic)</li></ul>

<div role="navigation" class="navbox" aria-labelledby="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="font-size:114%;margin:0 4em">Intracellular chemotherapeutic agents<span>&nbsp;</span>/ antineoplastic agents (L01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">SPs/MIs<br>(M phase)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule assembly</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Vinca alkaloids</i> (<a href="Vinblastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinblastine" title="Vinblastine">Vinblastine</a><sup>#</sup></li>
<li><a href="Vincristine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vincristine" title="Vincristine">Vincristine</a><sup>#</sup></li>
<li><a href="Vindesine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vindesine" title="Vindesine">Vindesine</a></li>
<li>Vinflunine<sup>§</sup></li>
<li><a href="Vinorelbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinorelbine" title="Vinorelbine">Vinorelbine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule disassembly</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Taxanes</i> (Cabazitaxel</li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a><sup>#</sup></li>
<li>Larotaxel</li>
<li>Ortataxel<sup>†</sup></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a><sup>#</sup></li>
<li>Tesetaxel)</li>
<li><i>Epothilones</i> (Ixabepilone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DNA replication<br>inhibitor</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA precursors/<br>antimetabolites<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Folic acid</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Dihydrofolate reductase inhibitor</i> (<a href="Aminopterin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminopterin" title="Aminopterin">Aminopterin</a></li>
<li><a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a><sup>#</sup></li>
<li><a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li>Pralatrexate)</li>
<li><i>Thymidylate synthase inhibitor</i> (<a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="Raltitrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Raltitrexed" title="Raltitrexed">Raltitrexed</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Purine</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Adenosine deaminase inhibitor</i> (<a href="Pentostatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentostatin" title="Pentostatin">Pentostatin</a>)</li></ul>

<ul><li><i>Halogenated/ribonucleotide reductase inhibitors</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Cladribine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Cladribine'" tppabs="https://ptable.com/wiki/compounds/A/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="Clofarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofarabine" title="Clofarabine">Clofarabine</a></li>
<li><a href="Fludarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludarabine" title="Fludarabine">Fludarabine</a>)</li>
<li><a href="Nelarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelarabine" title="Nelarabine">Nelarabine</a></li></ul>

<ul><li><i>Thiopurine</i> (<a href="Mercaptopurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mercaptopurine" title="Mercaptopurine">Mercaptopurine</a><sup>#</sup></li>
<li><a href="Tioguanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tioguanine" title="Tioguanine">Tioguanine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Thymidylate synthase inhibitor</i> (<a href="Capecitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Capecitabine" title="Capecitabine">Capecitabine</a><sup>#</sup></li>
<li><a href="Carmofur.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmofur" title="Carmofur">Carmofur</a></li>
<li>Doxifluridine</li>
<li><a href="Floxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Floxuridine" title="Floxuridine">Floxuridine</a></li>
<li><a href="Fluorouracil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorouracil" title="Fluorouracil">Fluorouracil</a><sup>#</sup></li>
<li><a href="Tegafur.htm" tppabs="https://ptable.com/wiki/compounds/A/Tegafur" title="Tegafur">Tegafur</a> (+gimeracil/oteracil))</li></ul>

<ul><li><i>DNA polymerase inhibitor</i> (<a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">Cytarabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Gemcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemcitabine" title="Gemcitabine">Gemcitabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Hypomethylating agent</i> (<a href="Azacitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azacitidine" title="Azacitidine">Azacitidine</a></li>
<li>Decitabine)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Deoxyribonucleotide</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a><sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Topoisomerase inhibitors<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">I</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Camptotheca</i> (Belotecan</li>
<li><a href="Camptothecin.htm" tppabs="https://ptable.com/wiki/compounds/A/Camptothecin" title="Camptothecin">Camptothecin</a></li>
<li><span class="new">Cositecan</span><sup>†</sup></li>
<li>Exatecan</li>
<li><span class="new">Gimatecan</span></li>
<li><a href="Irinotecan.htm" tppabs="https://ptable.com/wiki/compounds/A/Irinotecan" title="Irinotecan">Irinotecan</a><sup>#</sup></li>
<li>Lurtotecan<sup>‡</sup></li>
<li>Rubitecan<sup>‡</sup></li>
<li><span class="new">Silatecan</span><sup>§</sup></li>
<li>Topotecan)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Podophyllum</i> (<a href="Etoposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoposide" title="Etoposide">Etoposide</a><sup>#</sup></li>
<li><a href="Teniposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Teniposide" title="Teniposide">Teniposide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II+Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Anthracyclines</i> (Aclarubicin</li>
<li>Amrubicin<sup>†</sup></li>
<li><a href="Daunorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Daunorubicin" title="Daunorubicin">Daunorubicin</a><sup>#</sup></li>
<li><a href="Doxorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxorubicin" title="Doxorubicin">Doxorubicin</a><sup>#</sup></li>
<li><a href="Epirubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epirubicin" title="Epirubicin">Epirubicin</a></li>
<li><a href="Idarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Idarubicin" title="Idarubicin">Idarubicin</a></li>
<li><a href="Pirarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirarubicin" title="Pirarubicin">Pirarubicin</a></li>
<li><a href="Valrubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Valrubicin" title="Valrubicin">Valrubicin</a></li>
<li>Zorubicin)</li>
<li><i><a href="Anthraquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Anthraquinone" title="Anthraquinone">Anthracenediones</a></i> (<a href="Mitoxantrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li>Pixantrone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Crosslinking of DNA<br>(CCNS)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Alkylating</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nitrogen mustards:</i> Bendamustine<sup>#</sup></li>
<li>Chlormethine</li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a><sup>#</sup> (<a href="Ifosfamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ifosfamide" title="Ifosfamide">Ifosfamide</a><sup>#</sup></li>
<li>Trofosfamide)</li>
<li><a href="Chlorambucil.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorambucil" title="Chlorambucil">Chlorambucil</a><sup>#</sup> (<a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">Melphalan</a></li>
<li><a href="Prednimustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednimustine" title="Prednimustine">Prednimustine</a>)</li>
<li><a href="Uramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Uramustine" title="Uramustine">Uramustine</a></li></ul>

<ul><li><i>Nitrosoureas:</i> <a href="Carmustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmustine" title="Carmustine">Carmustine</a></li>
<li><a href="Fotemustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fotemustine" title="Fotemustine">Fotemustine</a></li>
<li><a href="Lomustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lomustine" title="Lomustine">Lomustine</a> (<a href="Semustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Semustine" title="Semustine">Semustine</a>)</li>
<li>Nimustine</li>
<li>Ranimustine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Streptozotocin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Streptozotocin'" tppabs="https://ptable.com/wiki/compounds/A/Streptozotocin" title="Streptozotocin">Streptozocin</a></li></ul>

<ul><li><i>Alkyl sulfonates:</i> <a href="Busulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Busulfan" title="Busulfan">Busulfan</a> (Mannosulfan</li>
<li><a href="Treosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Treosulfan" title="Treosulfan">Treosulfan</a>)</li></ul>

<ul><li><i><a href="Aziridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aziridine" title="Aziridine">Aziridines</a>:</i> Carboquone</li>
<li>Thiotepa</li>
<li><a href="Triaziquone.htm" tppabs="https://ptable.com/wiki/compounds/A/Triaziquone" title="Triaziquone">Triaziquone</a></li>
<li><a href="Triethylenemelamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triethylenemelamine" title="Triethylenemelamine">Triethylenemelamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Platinum-based</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Carboplatin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Carboplatin'" tppabs="https://ptable.com/wiki/compounds/A/Carboplatin" title="Carboplatin">Carboplatin</a><sup>#</sup></li>
<li><a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">Cisplatin</a><sup>#</sup></li>
<li>Dicycloplatin</li>
<li>Nedaplatin</li>
<li><a href="Oxaliplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a><sup>#</sup></li>
<li>Satraplatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nonclassical</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Altretamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Altretamine" title="Altretamine">Altretamine</a></li>
<li><i><a href="Hydrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrazine" title="Hydrazine">Hydrazines</a></i> (<a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a><sup>#</sup>)</li>
<li><a href="Mitobronitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitobronitol" title="Mitobronitol">Mitobronitol</a></li>
<li><a href="Pipobroman.htm" tppabs="https://ptable.com/wiki/compounds/A/Pipobroman" title="Pipobroman">Pipobroman</a></li>
<li><i>Triazenes</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Dacarbazine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Dacarbazine'" tppabs="https://ptable.com/wiki/compounds/A/Dacarbazine" title="Dacarbazine">Dacarbazine</a><sup>#</sup></li>
<li><a href="Temozolomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Temozolomide" title="Temozolomide">Temozolomide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Streptomyces (<a href="Actinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Actinomycin" title="Actinomycin" class="mw-redirect">Actinomycin</a><sup>#</sup></li>
<li><a href="Bleomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bleomycin" title="Bleomycin">Bleomycin</a><sup>#</sup></li>
<li>Mitomycins</li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Photosensitizers/PDT</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aminolevulinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminolevulinic_acid" title="Aminolevulinic acid">Aminolevulinic acid</a><span>&nbsp;</span>/ <a href="Methyl_aminolevulinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_aminolevulinate" title="Methyl aminolevulinate">Methyl aminolevulinate</a></li>
<li>Efaproxiral</li>
<li>Padeliporfin</li>
<li><i><a href="Porphyrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Porphyrin" title="Porphyrin">Porphyrin derivatives</a></i> (<a href="Porfimer_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Porfimer_sodium" title="Porfimer sodium">Porfimer sodium</a></li>
<li>Talaporfin</li>
<li>Temoporfin</li>
<li><a href="Verteporfin.htm" tppabs="https://ptable.com/wiki/compounds/A/Verteporfin" title="Verteporfin">Verteporfin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Enzyme inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>FI</i> (Tipifarnib<sup>§</sup>)</li>
<li><i>CDK inhibitors</i> (Abemaciclib</li>
<li>Alvocidib<sup>†</sup></li>
<li>Palbociclib</li>
<li>Ribociclib</li>
<li>Seliciclib<sup>†</sup>)</li>
<li><i>PrI</i>
<ul><li><a href="Bortezomib.htm" tppabs="https://ptable.com/wiki/compounds/A/Bortezomib" title="Bortezomib">Bortezomib</a></li>
<li>Carfilzomib</li>
<li>Ixazomib</li></ul></li>
<li><i>PhI</i> (<a href="Anagrelide.htm" tppabs="https://ptable.com/wiki/compounds/A/Anagrelide" title="Anagrelide">Anagrelide</a>)</li>
<li><i>IMPDI</i> (Tiazofurin<sup>§</sup>)</li>
<li><i>LI</i> (<a href="Masoprocol.htm" tppabs="https://ptable.com/wiki/compounds/A/Masoprocol" title="Masoprocol">Masoprocol</a>)</li>
<li><i>PARP inhibitor</i> (Niraparib</li>
<li>Olaparib</li>
<li>Rucaparib)</li>
<li><i>HDAC</i> (Belinostat</li>
<li>Panobinostat</li>
<li>Romidepsin</li>
<li><a href="Vorinostat.htm" tppabs="https://ptable.com/wiki/compounds/A/Vorinostat" title="Vorinostat">Vorinostat</a>)</li>
<li><i>PIKI</i> (Alpelisib</li>
<li>Idelalisib)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Receptor antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>ERA</i> (Atrasentan)</li>
<li><i>Retinoid X receptor</i> (<a href="Bexarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Bexarotene" title="Bexarotene">Bexarotene</a>)</li>
<li><i>Sex steroid</i> (<a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other/ungrouped</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amsacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amsacrine" title="Amsacrine">Amsacrine</a></li>
<li><a href="Arsenic_trioxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Arsenic_trioxide" title="Arsenic trioxide">Arsenic trioxide</a></li>
<li><i><a href="Asparagine.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparagine" title="Asparagine">Asparagine depleters</a></i> (<a href="Asparaginase.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparaginase" title="Asparaginase">Asparaginase</a><sup>#</sup>/<a href="Pegaspargase.htm" tppabs="https://ptable.com/wiki/compounds/A/Pegaspargase" title="Pegaspargase">Pegaspargase</a>)</li>
<li><a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li>Elesclomol<sup>§</sup></li>
<li>Elsamitrucin</li>
<li>Eribulin</li>
<li>Estramustine phosphate</li>
<li><a href="Etoglucid.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoglucid" title="Etoglucid">Etoglucid</a></li>
<li><a href="Lonidamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li>Lucanthone</li>
<li>Mitoguazone</li>
<li><a href="Mitotane.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitotane" title="Mitotane">Mitotane</a></li>
<li>Oblimersen<sup>†</sup></li>
<li>Omacetaxine mepesuccinate</li>
<li>Trabectedin</li>
<li><i>Retinoids</i> (<a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a><sup>#</sup>)</li>
<li>Venetoclax</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Xenobiotic-sensing_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Xenobiotic-sensing_receptor_modulators" style="font-size:114%;margin:0 4em">Xenobiotic-sensing receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>CAR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> <span class="new">6,7-Dimethylesculetin</span></li>
<li><a href="Amiodarone.htm" tppabs="https://ptable.com/wiki/compounds/A/Amiodarone" title="Amiodarone">Amiodarone</a></li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><span class="new">Benfuracarb</span></li>
<li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Carvedilol.htm" tppabs="https://ptable.com/wiki/compounds/A/Carvedilol" title="Carvedilol">Carvedilol</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li><a href="Chrysin.htm" tppabs="https://ptable.com/wiki/compounds/A/Chrysin" title="Chrysin">Chrysin</a></li>
<li><span class="new">CITCO</span></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li><a href="Cypermethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cypermethrin" title="Cypermethrin">Cypermethrin</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Efavirenz.htm" tppabs="https://ptable.com/wiki/compounds/A/Efavirenz" title="Efavirenz">Efavirenz</a></li>
<li><a href="Ellagic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Ellagic_acid" title="Ellagic acid">Ellagic acid</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li><a href="Methoxychlor.htm" tppabs="https://ptable.com/wiki/compounds/A/Methoxychlor" title="Methoxychlor">Methoxychlor</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nefazodone.htm" tppabs="https://ptable.com/wiki/compounds/A/Nefazodone" title="Nefazodone">Nefazodone</a></li>
<li><a href="Nevirapine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nevirapine" title="Nevirapine">Nevirapine</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><span class="new">Octicizer</span></li>
<li><a href="Permethrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Permethrin" title="Permethrin">Permethrin</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">Phenytoin</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li><span class="new">TCPOBOP</span></li>
<li><a href="Telmisartan.htm" tppabs="https://ptable.com/wiki/compounds/A/Telmisartan" title="Telmisartan">Telmisartan</a></li>
<li><a href="Tolnaftate.htm" tppabs="https://ptable.com/wiki/compounds/A/Tolnaftate" title="Tolnaftate">Tolnaftate</a></li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li></ul>

<ul><li><i>Antagonists:</i> <span class="new">3,17β-Estradiol</span></li>
<li><span class="new">3α-Androstanol</span></li>
<li>3α-Androstenol</li>
<li><span class="new">3β-Androstanol</span></li>
<li><span class="new">17-Androstanol</span></li>
<li><a href="Allyl_isothiocyanate.htm" tppabs="https://ptable.com/wiki/compounds/A/Allyl_isothiocyanate" title="Allyl isothiocyanate">AITC</a></li>
<li>Ethinylestradiol</li>
<li>Meclizine</li>
<li><span class="new">Nigramide J</span></li>
<li><a href="Okadaic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Okadaic_acid" title="Okadaic acid">Okadaic acid</a></li>
<li>PK-11195</li>
<li><span class="new">S-07662</span></li>
<li><span class="new">T-0901317</span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PXR</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Agonists:</i> 17α-Hydroxypregnenolone</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Androstenedione.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%944-Androstenedione" title="Δ4-Androstenedione" class="mw-redirect">Δ<sup>4</sup>-Androstenedione</a></li>
<li><a href="Androstenediol.htm" tppabs="https://ptable.com/wiki/compounds/A/%CE%945-Androstenediol" title="Δ5-Androstenediol" class="mw-redirect">Δ<sup>5</sup>-Androstenediol</a></li>
<li>Δ<sup>5</sup>-Androstenedione</li>
<li><span class="new">AA-861</span></li>
<li>Allopregnanediol</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">Allopregnanedione (5α-dihydroprogesterone)</a></li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone (brexanolone)</a></li>
<li>Alpha-Lipoic acid</li>
<li>Ambrisentan</li>
<li>AMI-193</li>
<li>Amlodipine besylate</li>
<li>Antimycotics</li>
<li><a href="Artemisinin.htm" tppabs="https://ptable.com/wiki/compounds/A/Artemisinin" title="Artemisinin">Artemisinin</a></li>
<li><a href="Aurothioglucose.htm" tppabs="https://ptable.com/wiki/compounds/A/Aurothioglucose" title="Aurothioglucose">Aurothioglucose</a></li>
<li>Bile acids</li>
<li><a href="Bithionol.htm" tppabs="https://ptable.com/wiki/compounds/A/Bithionol" title="Bithionol">Bithionol</a></li>
<li><a href="Bosentan.htm" tppabs="https://ptable.com/wiki/compounds/A/Bosentan" title="Bosentan">Bosentan</a></li>
<li><span class="new">Bumecaine</span></li>
<li>Cafestol</li>
<li><a href="Cephaloridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephaloridine" title="Cephaloridine">Cephaloridine</a></li>
<li><a href="Cefradine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cephradine" title="Cephradine" class="mw-redirect">Cephradine</a></li>
<li><a href="Chlorpromazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorpromazine" title="Chlorpromazine">Chlorpromazine</a></li>
<li>Ciglitazone</li>
<li><a href="Clindamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clindamycin" title="Clindamycin">Clindamycin</a></li>
<li>Clofenvinfos</li>
<li><a href="Chloroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroxine" title="Chloroxine">Chloroxine</a></li>
<li><a href="Clotrimazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Clotrimazole" title="Clotrimazole">Clotrimazole</a></li>
<li><a href="Colforsin.htm" tppabs="https://ptable.com/wiki/compounds/A/Colforsin" title="Colforsin">Colforsin</a></li>
<li><a href="Corticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Corticosterone" title="Corticosterone">Corticosterone</a></li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a></li>
<li>Cyproterone acetate</li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li><a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">Dexamethasone</a></li>
<li><a href="Dehydroepiandrosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone" title="Dehydroepiandrosterone">DHEA</a> (prasterone)</li>
<li><a href="Dehydroepiandrosterone_sulfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Dehydroepiandrosterone_sulfate" title="Dehydroepiandrosterone sulfate">DHEA-S</a> (prasterone sulfate)</li>
<li>Dibunate sodium</li>
<li>Diclazuril</li>
<li><a href="Dicloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Dicloxacillin" title="Dicloxacillin">Dicloxacillin</a></li>
<li><a href="Dimercaprol.htm" tppabs="https://ptable.com/wiki/compounds/A/Dimercaprol" title="Dimercaprol">Dimercaprol</a></li>
<li><span class="new">Dinaline</span></li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a></li>
<li>Docusate calcium</li>
<li>Dodecylbenzenesulfonic acid</li>
<li>Dronabinol</li>
<li>Droxidopa</li>
<li><a href="Vinburnine.htm" tppabs="https://ptable.com/wiki/compounds/A/Eburnamonine" title="Eburnamonine" class="mw-redirect">Eburnamonine</a></li>
<li>Ecopipam</li>
<li>Enzacamene</li>
<li>Epothilone B</li>
<li><a href="Erythromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Erythromycin" title="Erythromycin">Erythromycin</a></li>
<li>Famprofazone</li>
<li><span class="new">Febantel</span></li>
<li><a href="Felodipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Felodipine" title="Felodipine">Felodipine</a></li>
<li><a href="Fenbendazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Fenbendazole" title="Fenbendazole">Fenbendazole</a></li>
<li><a href="Fentanyl.htm" tppabs="https://ptable.com/wiki/compounds/A/Fentanyl" title="Fentanyl">Fentanyl</a></li>
<li><a href="Flucloxacillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Flucloxacillin" title="Flucloxacillin">Flucloxacillin</a></li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li><a href="Griseofulvin.htm" tppabs="https://ptable.com/wiki/compounds/A/Griseofulvin" title="Griseofulvin">Griseofulvin</a></li>
<li>Guggulsterone</li>
<li><a href="Haloprogin.htm" tppabs="https://ptable.com/wiki/compounds/A/Haloprogin" title="Haloprogin">Haloprogin</a></li>
<li>Hetacillin potassium</li>
<li><a href="Hyperforin.htm" tppabs="https://ptable.com/wiki/compounds/A/Hyperforin" title="Hyperforin">Hyperforin</a></li>
<li><i>Hypericum perforatum</i> (St John's wort)</li>
<li>Indinavir sulfate</li>
<li>Lasalocid sodium</li>
<li><a href="Levothyroxine.htm" tppabs="https://ptable.com/wiki/compounds/A/Levothyroxine" title="Levothyroxine">Levothyroxine</a></li>
<li><a href="Linolenic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Linolenic_acid" title="Linolenic acid">Linolenic acid</a></li>
<li><span class="new">LOE-908</span></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li><a href="Lovastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Lovastatin" title="Lovastatin">Lovastatin</a></li>
<li>Meclizine</li>
<li><a href="Metacycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Metacycline" title="Metacycline">Metacycline</a></li>
<li><a href="Methylprednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methylprednisolone" title="Methylprednisolone">Methylprednisolone</a></li>
<li><a href="Metyrapone.htm" tppabs="https://ptable.com/wiki/compounds/A/Metyrapone" title="Metyrapone">Metyrapone</a></li>
<li><a href="Mevastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Mevastatin" title="Mevastatin">Mevastatin</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Nafcillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Nafcillin" title="Nafcillin">Nafcillin</a></li>
<li><a href="Nicardipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicardipine" title="Nicardipine">Nicardipine</a></li>
<li><a href="Nicotine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nicotine" title="Nicotine">Nicotine</a></li>
<li><a href="Nifedipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nifedipine" title="Nifedipine">Nifedipine</a></li>
<li>Nilvadipine</li>
<li><a href="Nisoldipine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nisoldipine" title="Nisoldipine">Nisoldipine</a></li>
<li>Norelgestromin</li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a></li>
<li><a href="Orlistat.htm" tppabs="https://ptable.com/wiki/compounds/A/Orlistat" title="Orlistat">Orlistat</a></li>
<li><a href="Oxatomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxatomide" title="Oxatomide">Oxatomide</a></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a></li>
<li><a href="Phenobarbital.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenobarbital" title="Phenobarbital">Phenobarbital</a></li>
<li><a href="Piperine.htm" tppabs="https://ptable.com/wiki/compounds/A/Piperine" title="Piperine">Piperine</a></li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a></li>
<li><a href="Prednisolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednisolone" title="Prednisolone">Prednisolone</a></li>
<li><a href="Pregnanediol.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnanediol" title="Pregnanediol">Pregnanediol</a></li>
<li>Pregnanedione (5β-dihydroprogesterone)</li>
<li>Pregnanolone</li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li>Pregnenolone 16α-carbonitrile</li>
<li>Proadifen</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Quingestrone</li>
<li><a href="Reserpine.htm" tppabs="https://ptable.com/wiki/compounds/A/Reserpine" title="Reserpine">Reserpine</a></li>
<li>Reverse triiodothyronine</li>
<li><a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li>
<li><a href="Rifaximin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifaximin" title="Rifaximin">Rifaximin</a></li>
<li><a href="Rimexolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimexolone" title="Rimexolone">Rimexolone</a></li>
<li>Riodipine</li>
<li><a href="Ritonavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ritonavir" title="Ritonavir">Ritonavir</a></li>
<li><a href="Simvastatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Simvastatin" title="Simvastatin">Simvastatin</a></li>
<li><a href="Sirolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Sirolimus" title="Sirolimus">Sirolimus</a></li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spiroxatrine</li>
<li><span class="new">SR-12813</span></li>
<li><span class="new">Suberoylanilide</span></li>
<li>Sulfisoxazole</li>
<li><a href="Suramin.htm" tppabs="https://ptable.com/wiki/compounds/A/Suramin" title="Suramin">Suramin</a></li>
<li><a href="Tacrolimus.htm" tppabs="https://ptable.com/wiki/compounds/A/Tacrolimus" title="Tacrolimus">Tacrolimus</a></li>
<li><span class="new">Tenylidone</span></li>
<li><a href="Terconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Terconazole" title="Terconazole">Terconazole</a></li>
<li>Testosterone isocaproate</li>
<li><a href="Tetracycline.htm" tppabs="https://ptable.com/wiki/compounds/A/Tetracycline" title="Tetracycline">Tetracycline</a></li>
<li>Thiamylal sodium</li>
<li><a href="Thiothixene.htm" tppabs="https://ptable.com/wiki/compounds/A/Thiothixene" title="Thiothixene" class="mw-redirect">Thiothixene</a></li>
<li>Thonzonium bromide</li>
<li>Tianeptine</li>
<li><a href="Troglitazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Troglitazone" title="Troglitazone">Troglitazone</a></li>
<li><a href="Troleandomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Troleandomycin" title="Troleandomycin">Troleandomycin</a></li>
<li><span class="new">Tropanyl 3,5-dimethulbenzoate</span></li>
<li><a href="Zafirlukast.htm" tppabs="https://ptable.com/wiki/compounds/A/Zafirlukast" title="Zafirlukast">Zafirlukast</a></li>
<li><a href="Zeranol.htm" tppabs="https://ptable.com/wiki/compounds/A/Zeranol" title="Zeranol">Zeranol</a></li></ul>

<ul><li><i>Antagonists:</i> <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">Ketoconazole</a></li>
<li><a href="Sesamin.htm" tppabs="https://ptable.com/wiki/compounds/A/Sesamin" title="Sesamin">Sesamin</a></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd><i>Receptor/signaling modulators</i></dd></dl>
</div></td></tr></tbody></table></div><span>
</span>












<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-07-31" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Docetaxel&oldid=970498427  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Docetaxel&oldid=970498427'" tppabs="https://en.wikipedia.org/wiki/?title=Docetaxel&oldid=970498427">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>